Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anti-CD2O chimeric monoclonal antibody (rituximab) treatment of immune-mediated thrombocytopenia associated with Crohn's disease.

× No keyword cloud information.

5 in total

1. B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice.

Authors: Yuki Moritoki; Zhe-Xiong Lian; Keith Lindor; Joseph Tuscano; Koichi Tsuneyama; Weici Zhang; Yoshiyuki Ueno; Robert Dunn; Marilyn Kehry; Ross L Coppel; Ian R Mackay; M Eric Gershwin
Journal: Hepatology Date: 2009-12 Impact factor: 17.425

2. Systemic adverse events following rituximab therapy in patients with Graves' disease.

Authors: D El Fassi; C H Nielsen; P Junker; H C Hasselbalch; L Hegedüs
Journal: J Endocrinol Invest Date: 2010-12-15 Impact factor: 4.256

3. T regulatory cells and B cells cooperate to form a regulatory loop that maintains gut homeostasis and suppresses dextran sulfate sodium-induced colitis.

Authors: L Wang; A Ray; X Jiang; J-y Wang; S Basu; X Liu; T Qian; R He; B N Dittel; Y Chu
Journal: Mucosal Immunol Date: 2015-03-25 Impact factor: 7.313

Review 4. Immunopathogenesis of granulomas in chronic autoinflammatory diseases.

Authors: Wilhelmina Maria Cornelia Timmermans; Jan Alexander Michael van Laar; Petrus Martinus van Hagen; Menno Cornelis van Zelm
Journal: Clin Transl Immunology Date: 2016-12-16

5. B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.

Authors: Wilhelmina M C Timmermans; Jan A M van Laar; Tim B van der Houwen; Lieke S J Kamphuis; Sophinus J W Bartol; King H Lam; Rob J Ouwendijk; Miles P Sparrow; Peter R Gibson; P Martin van Hagen; Menno C van Zelm
Journal: PLoS One Date: 2016-07-28 Impact factor: 3.240

5 in total